Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07469605 · ClinicalTrials.gov registry record · NA

Hysteroscopy for the Diagnosis and Treatment of Pregnancy of Unknown Location

A NA study of Pregnancy of Unknown Location, sponsored by University of Pennsylvania.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT07469605: Recruiting NA study of Pregnancy of Unknown Location, sponsored by University of Pennsylvania.

NCT07469605 is a NA study of Pregnancy of Unknown Location that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07469605, a NA study of Pregnancy of Unknown Location, is actively recruiting participants, sponsored by University of Pennsylvania.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Infertility patients have a higher baseline risk of ectopic pregnancy compared to the general population. If an early pregnancy is not visible by ultrasound, patients with a pregnancy of unknown location (PUL) will undergo uterine aspiration (D\&C) in order to diagnose an ectopic pregnancy and/or treat an abnormal intrauterine pregnancy destined for miscarriage. If the pathologic specimen obtained after D\&C does not contain chorionic villi, the presumptive diagnosis of ectopic pregnancy is made and methotrexate therapy is typically recommended. In many institutions, a D\&C must be scheduled in the operating room so that it may be performed under anesthesia, potentially delaying the urgent treatment of ectopic pregnancy. Office hysteroscopy is a safe and well-tolerated means of evaluating the uterine cavity, though little literature exists supporting its use in the evaluation of PUL. The objective of this study is to compare hysteroscopic biopsy to the gold standard D\&C for the diagnosis and treatment of PUL. The investigators propose a prospective study including patients undergoing care at the University of Pennsylvania. Patients will be included if they have at least three bHCG values demonstrating a \<50% increase in over 48 hours. A hysteroscopy with possible biopsy followed by uterine aspiration will be performed, and the final pathology results will be compared. Although pathology results from the procedure are considered the gold standard of diagnosis, physicians typically do not wait for results to return before proceeding with necessary treatment. Instead, all patients will have a serum bHCG drawn on post-operative day 1, and those with a \<50% decrease compared to pre-procedural values will undergo treatment with methotrexate therapy per institutional protocol. The findings from this pilot study will inform future research comparing hysteroscopic vs. D\&C for management of PUL. If hysteroscopic targeted biopsy is more accurate than D\&C in detecting an

Primary Outcome

Intra-operative photographs will be taken of the participants uterine cavities at five standardized locations (left cornua, right cornua, anterior uterine wall, posterior uterine wall, and entire uterine cavity at level of internal os). The presence or absence of abnormal tissue will be documented, and findings qualitatively compared between the cavities of participants with the final diagnosis of non-viable intrauterine pregnancy and an ectopic pregnancy.

Interventions

  • DIAGNOSTIC_TEST Hysteroscopy for diagnosis and treatment of pregnancy of unknown location

Study Locations (1)

Pennsylvania

  • Penn Fertility Care - Philadelphia

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2026-01-15
Est. Completion 2027-01-01
Phase NA
University of Pennsylvania

1,423 total trials

What NCT07469605 shows while recruiting

NCT07469605 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Pregnancy of Unknown Location appearing as the primary indexed condition, and to 1 intervention - of which Hysteroscopy for diagnosis and treatment of pregnancy of unknown location is the first listed.

NCT07469605 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT07469605 about?

NCT07469605 is a clinical study titled "Hysteroscopy for the Diagnosis and Treatment of Pregnancy of Unknown Location". Infertility patients have a higher baseline risk of ectopic pregnancy compared to the general population. If an early pregnancy is not visible by ultrasound, patients with a pregnancy of unknown location (PUL) will undergo uterine aspiration (D\&C) in order to diagnose an ectopic pregnancy and/or tr...

What is the current status of trial NCT07469605?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-01-15. Estimated completion is 2027-01-01.

What conditions does trial NCT07469605 study?

This clinical trial studies the following conditions: Pregnancy of Unknown Location.

What interventions are being tested in trial NCT07469605?

The interventions under investigation include: Hysteroscopy for diagnosis and treatment of pregnancy of unknown location (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT07469605?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07469605 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT07469605's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07469605, the US trial registry maintained by the National Library of Medicine. NCT07469605 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.